ExcitaPlus

Neuroscience ExcitaPlus

Произведено Neuroscience
В наличии
Код товара: P001818
Наша цена:
₸41 757
Contains non-glandular ingredients important for adrenal health and reducing stress-induced fatigue* Provides more than three times the L-tyrosine and six times the Rhodiola per capsule compared to AdreCor Key ingredients L-tyrosine: Precursor to catecholamines including dopamine, norepinephrine and epinephrine. Rhodiola rosea root extract (5% rosavins): Adaptogen that has been shown to reduce stress-induced effects (1,2).* In a randomized, double-blind, placebo-controlled study, Rhodiola rosea was shown to significantly reduce mental fatigue and improve general well-being under stress (2).* L-methionine: Precursor to S-adenosylmethionine (SAMe) (3). SAMe is directly involved in methylation processes including catecholamine synthesis (4). Mucuna cochinchinensis (99% L-DOPA): Natural source of L-DOPA (9). L-DOPA crosses the blood-brain barrier and is a precursor to catecholamines (10).* Vitamins B and C: Active forms of pantothenic acid, niacin, B6, folate, and C are important for the synthesis of adrenal hormones and catecholamines (11-15).* *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. References 1. Blier P. J Psychiatry Neurosci. 2001;26 Suppl:S1-2. 2. Verhoeff N, et al. Pharmacol Biochem Behav. 2003;74(2):425-32. 3. Xing B, et al. Brain Res. 2016;1641(Pt B):217-33. 4. Clark K and Noudoost B. Front Neural Circuits. 2014;8:33. 5. Chiang H, et al. J Food Drug Anal. 2015;23(3):359-69. 6. Spasov A, et al. Phytomedicine. 2000;7(2):85-9. 7. Duncan T, et al. Mol Nutr Food Res. 2013;57(4):628-36. 8. Mischoulon D and Fava M. Am J Clin Nutr. 2002;76(5):1158S-61S. 9. Tuleun C, et al. Livestock Research for Rural Development. 2008;20(10). 10. Pardridge W. NeuroRx. 2005:2(1):3-14. 11. Ragaller V, et al. J Anim Physiol Anim Nutr (Berl). 2011;95(1):6-16. 12. Vrecko K, et al. Biochim Biophys Acta. 1997;1361(1):59-65. 13. May J, et al. Brain Res Bull. 2013;90:35-42. 14. Antoniades C, et al. Circulation. 2006;114(11):1193-201. 15. Mattson M and Shea T. Trends Neurosci. 2003;26(3):137-46.